Tamoxifen inhibits migration of estrogen receptor-negative hepatocellular carcinoma cells by blocking the swelling-activated chloride current

Journal of Cellular Physiology

Volumn 228, Issue 5, 2013, Pages 991-1001

  Mao, Jianwen ^a,b   Yuan, Jian ^b   Wang, Liwei ^a   Zhang, Haifeng ^a   Jin, Xiaobao ^b   Zhu, Jiayong ^b   Li, Hongzhi ^b   Xu, Bin ^b   Chen, Lixin ^a  

^a MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

^b GUANGDONG PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED CHLORIDE CHANNEL; ESTROGEN RECEPTOR; PROTEIN KINASE C; TAMOXIFEN;

ARTICLE; CELL MIGRATION; CELL VOLUME; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LIVER CELL CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; WESTERN BLOTTING;

ANTINEOPLASTIC AGENTS; CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL MOVEMENT; CELL SIZE; CHLORIDE CHANNELS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LIVER NEOPLASMS; NEOPLASM METASTASIS; RECEPTORS, ESTROGEN; RNA, SMALL INTERFERING; TAMOXIFEN; TETRADECANOYLPHORBOL ACETATE;

EID: 84873836586     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24245     Document Type: Article

References (57)

1. Ariazi EA, Ariazi JL, Cordera F, Jordan VC. 2006. Estrogen receptors as therapeutic targets in breast cancer. Curr Top Med Chem 6:181-202.
2. Cantiello HF, Prat AG, Bonventre JV, Cunningham CC, Hartwig JH, Ausiello DA. 1993. Actin-binding protein contributes to cell volume regulatory ion channel activation in melanoma cells. J Biol Chem 268:4596-4599.
3. Chen L, Wang L, Zhu L, Nie S, Zhang J, Zhong P, Cai B, Luo H, Jacob TJ. 2002. Cell cycle-dependent expression of volume-activated chloride currents in nasopharyngeal carcinoma cells. Am J Physiol Cell Physiol 283:C1313-C1323.
4. Chou CY, Shen MR, Hsu KS, Huang HY, Lin HC. 1998. Involvement of PKC-alpha in regulatory volume decrease responses and activation of volume-sensitive chloride channels in human cervical cancer HT-3 cells. J Physiol 512:435-448.
5. Cocconi G, Bella M, Calabresi F, Tonato M, Canaletti R, Boni C, Buzzi F, Ceci G, Corgna E, Costa P, Lottici R, Papadia F, Sofra MC, Bacchi M. 1992. Treatment of metastatic malignant melanoma with dacarbazine plus tamoxifen. N Engl J Med 327:516-523.
6. Cuddapah VA, Sontheimer H. 2011. Ion channels and transporters in cancer. 2. Ion channels and the control of cancer cell migration. Am J Physiol Cell Physiol 301:C541-C549.
7. Ding F, Zhang G, Liu L, Jiang L, Wang R, Zheng Y, Wang G, Xie M, Duan Y. 2012. Involvement of cationic channels in proliferation and migration of human mesenchymal stem cells. Tissue Cell (Epub ahead of print).
8. - currents by functional anti-ClC-3 antibody in native bovine non-pigmented ciliary epithelial cells. Invest Ophthalmol Vis Sci 46:948-955.
9. Duan D, Winter C, Cowley S, Hume JR, Horowitz B. 1997. Molecular identification of a volume-regulated chloride channel. Nature 390:417-421.
10. Duffy SM, Lawley WJ, Kaur D, Yang W, Bradding P. 2003. Inhibition of human mast cell proliferation and survival by tamoxifen in association with ion channel modulation. J Allergy Clin Immunol 112:965-972.
11. Edelmann MN, Auger AP. 2011. Epigenetic impact of simulated maternal grooming on estrogen receptor alpha within the developing amygdala. Brain Behav Immun 25:1299-1304.
12. Fraser SP, Pardo LA. 2008. Ion channels: Functional expression and therapeutic potential in cancer. Colloquium on ion channels and cancer. EMBO Rep 9:512-515.
13. - channel in cell volume regulation, proliferation and apoptosis in vascular smooth muscle cells. Trends Pharmacol Sci 27:290-296.
14. Hendriks R, Morest DK, Kaczmarek LK. 1999. Role in neuronal cell migration for high-threshold potassium currents in the chicken hindbrain. J Neurosci Res 58:805-814.
15. Hoelting T, Duh QY, Clark OH, Herfarth C. 1996. Tamoxifen antagonizes proliferation and invasion of estrogen receptor-negative metastatic follicular thyroid cancer cells via protein kinase C. Cancer Lett 100:89-93.
16. Horgan K, Cooke E, Hallett MB, Mansel RE. 1986. Inhibition of protein kinase C mediated signal transduction by tamoxifen. Importance for antitumour activity. Biochem Pharmacol 35:4463-4465.
17. - channels in the proliferation of human subcutaneous pre-adipocytes. Clin Exp Pharmacol Physiol 37:29-34.
18. Hughes-Davies L, Caldas C, Wishart GC. 2009. Tamoxifen: The drug that came in from the cold. Br J Cancer 101:875-878.
19. Jakab M, Ritter M. 2006. Cell volume regulatory ion transport in the regulation of cell migration. Contrib Nephrol 152:161-180.
20. Jin NG, Kim JK, Yang DK, Cho SJ, Kim JM, Koh EJ, Jung HC, So I, Kim KW. 2003. Fundamental role of ClC-3 in volume-sensitive Cl- channel function and cell volume regulation in AGS cells. Am J Physiol Gastrointest Liver Physiol 285:G938-G948.
21. 2+ entry and protein kinase Calpha in rat cerebral cortex nerve terminals. Neurochem Int 60:105-114.
22. Leaney JL, Marsh SJ, Brown DA. 1997. A swelling-activated chloride current in rat sympathetic neurones. J Physiol 501:555-564.
23. Lee J, Ishihara A, Oxford G, Johnson B, Jacobson K. 1999. Regulation of cell movement is mediated by stretch-activated calcium channels. Nature 400:382-386.
24. Lien EA, Solheim E, Ueland PM. 1991. Distribution of tamoxifen and its metabolites in rat and human tissues during steady-state treatment. Cancer Res 51:4837-4844.
25. Lissoni P, Ardizzoia A, Barni S, Paolorossi F, Tancini G, Meregalli S, Esposti D, Zubelewicz B, Braczowski R. 1995. A randomized study of tamoxifen alone versus tamoxifen plus melatonin in estrogen receptor-negative heavily pretreated metastatic breast-cancer patients. Oncol Rep 2:871-873.
26. - current in migrated nasopharyngeal carcinoma cells. Sheng Li Xue Bao 56:525-530.
27. Mao JW, Wang LW, Jacob T, Sun XR, Li H, Zhu LY, Li P, Zhong P, Nie SH, Chen LX. 2005. Involvement of regulatory volume decrease in the migration of nasopharyngeal carcinoma cells. Cell Res 15:371-378.
28. Mao J, Wang L, Fan A, Wang J, Xu B, Jacob TJ, Chen L. 2007. Blockage of volume-activated chloride channels inhibits migration of nasopharyngeal carcinoma cells. Cell Physiol Biochem 19:249-258.
29. Mao J, Chen L, Xu B, Wang L, Wang W, Li M, Zheng M, Li H, Guo J, Li W, Jacob TJ. 2009. Volume-activated chloride channels contribute to cell-cycle-dependent regulation of HeLa cell migration. Biochem Pharmacol 77:159-168.
30. - currents in hepatocellular carcinoma cells. J Cell Physiol 226:1176-1185.
31. Matsuda JJ, Filali MS, Volk KA, Collins MM, Moreland JG, Lamb FS. 2008. Overexpression of CLC-3 in HEK293T cells yields novel currents that are pH dependent. Am J Physiol Cell Physiol 294:C251-262.
32. Matsuoka H, Tsubaki M, Yamazoe Y, Ogaki M, Satou T, Itoh T, Kusunoki T, Nishida S. 2009. Tamoxifen inhibits tumor cell invasion and metastasis in mouse melanoma through suppression of PKC/MEK/ERK and PKC/PI3K/Akt pathways. Exp Cell Res 315:2022-2032.
33. McFerrin MB, Sontheimer H. 2006. A role for ion channels in glioma cell invasion. Neuron Glia Biol 2:39-49.
34. Moreland JG, Davis AP, Bailey G, Nauseef WM, Lamb FS. 2006. Anion channels, including ClC-3, are required for normal neutrophil oxidative function, phagocytosis, and transendothelial migration. J Biol Chem 281:12277-12288.
35. Morra A, Sponza M, Stanta G, Urban F, Frezza M. 1998. Complete remission of hepatocarcinoma metastasis during palliative treatment with tamoxifen. Radiol Med 96:263-265.
36. Nichols M. 2007. The fight against tamoxifen resistance in breast cancer therapy: A new target in the battle? Mol Interv 7:13-16.
37. O'Brian CA, Liskamp RM, Solomon DH, Weinstein IB. 1985. Inhibition of protein kinase C by tamoxifen. Cancer Res 45:2462-2465.
38. O'Day SJ, Boasberg PD, Kristedja TS, Martin M, Wang HJ, Fournier P, Cabot M, DeGregorio MW, Gammon G. 2001. High-dose tamoxifen added to concurrent biochemotherapy with decrescendo interleukin-2 in patients with metastatic melanoma. Cancer 92:609-619.
39. Prevarskaya N, Skryma R, Shuba Y. 2010. Ion channels and the hallmarks of cancer. Trends Mol Med 16:107-121.
40. Ramachandran C, Khatib Z, Petkarou A, Fort J, Fonseca HB, Melnick SJ, Escalon E. 2004. Tamoxifen modulation of etoposide cytotoxicity involves inhibition of protein kinase C activity and insulin-like growth factor II expression in brain tumor cells. J Neurooncol 67:19-28.
41. Ransom CB, O'Neal JT, Sontheimer H. 2001. Volume-activated chloride currents contribute to the resting conductance and invasive migration of human glioma cells. J Neurosci 21:7674-7683.
42. Sahebgharani M, Hardy SP, Lloyd AW, Hunter AC, Allen MC. 2001. Volume-activated chloride currents in HeLa cells are blocked by tamoxifen but not by a membrane impermeant quaternary analogue. Cell Physiol Biochem 11:99-104.
43. Schwab A. 2001a. Function and spatial distribution of ion channels and transporters in cell migration. Am J Physiol Renal Physiol 280:F739-F747.
44. Schwab A. 2001b. Ion channels and transporters on the move. News Physiol Sci 16:29-33.
45. Schwab A, Wojnowski L, Gabriel K, Oberleithner H. 1994. Oscillating activity of a Ca(2+)-sensitive K+ channel. A prerequisite for migration of transformed Madin-Darby canine kidney focus cells. J Clin Invest 93:1631-1636.
46. Shi C, Barnes S, Coca-Prados M, Kelly ME. 2002. Protein tyrosine kinase and protein phosphatase signaling pathways regulate volume-sensitive chloride currents in a nonpigmented ciliary epithelial cell line. Invest Ophthalmol Vis Sci 43:1525-1532.
47. Shuba LM, Ogura T, McDonald TF. 1996. Kinetic evidence distinguishing volume-sensitive chloride current from other types in guinea-pig ventricular myocytes. J Physiol 491:69-80.
48. Sontheimer H. 2008. An unexpected role for ion channels in brain tumor metastasis. Exp Biol Med (Maywood) 233:779-791.
49. Szucs G, Heinke S, De Greef C, Raeymaekers L, Eggermont J, Droogmans G, Nilius B. 1996. The volume-activated chloride current in endothelial cells from bovine pulmonary artery is not modulated by phosphorylation. Pflugers Arch 431:540-548.
50. Tang N, Xie Q, Wang X, Li X, Chen Y, Lin X, Lin J. 2011. Inhibition of invasion and metastasis of MHCC97H cells by expression of snake venom cystatin through reduction of proteinases activity and epithelial-mesenchymal transition. Arch Pharm Res 34:781-789.
51. - currents inhibit endothelial cell proliferation. Pflugers Arch 431:132-134.
52. Wei H, Mei YA, Sun JT, Zhou HQ, Zhang ZH. 2003. Regulation of swelling-activated chloride channels in embryonic chick heart cells. Cell Res 13:21-28.
53. Wiseman H, Cannon M, Arnstein HR, Barlow DJ. 1992. The structural mimicry of membrane sterols by tamoxifen: Evidence from cholesterol coefficients and molecular-modelling for its action as a membrane anti-oxidant and an anti-cancer agent. Biochim Biophys Acta 1138:197-202.
54. Xiong D, Wang GX, Burkin DJ, Yamboliev IA, Singer CA, Rawat S, Scowen P, Evans R, Ye L, Hatton WJ, Tian H, Keller PS, McCloskey DT, Duan D, Hume JR. 2009. Cardiac-specific overexpression of the human short CLC-3 chloride channel isoform in mice. Clin Exp Pharmacol Physiol 36:386-393.
55. Xu KP, Dartt DA, Yu FS. 2002. EGF-induced ERK phosphorylation independent of PKC isozymes in human corneal epithelial cells. Invest Ophthalmol Vis Sci 43:3673-3679.
56. Yin Z, Tong Y, Zhu H, Watsky MA. 2008. ClC-3 is required for LPA-activated Cl- current activity and fibroblast-to-myofibroblast differentiation. Am J Physiol Cell Physiol 294:C535-C542.
57. Zhang JJ, Jacob TJ, Valverde MA, Hardy SP, Mintenig GM, Sepulveda FV, Gill DR, Hyde SC, Trezise AE, Higgins CF. 1994. Tamoxifen blocks chloride channels. A possible mechanism for cataract formation. J Clin Invest 94:1690-1697.